Eric Konings is Public Affairs Manager NL for Kindred Group, one of
Since 2018, Hague has been managing the Secretariat of Medicinal Cannabis Europe (MCE), a pan European multi-stakeholder association that aims to ensure patients’ fair access to medicinal cannabis via the establishment of a harmonised EU regulatory framework.
The Single Convention on Narcotic Drugs (1961) restricts the use of the cannabis in the medical field. However, evidence demonstrates that medicinal cannabis can alleviate the pain brought by the side effects of cancer treatments or chronic pain experienced due to severe conditions such as multiple sclerosis and epilepsy. Consequently, the interest of the scientific and patients’ communities has gained ground over the recent years.
The legislation regulating medicinal cannabis across the Member States of the European Union (EU) is fragmented. Members States regulate the licensing, production, distribution, access and reimbursement of medicinal cannabis in different ways. Whilst the fragmentation hampers the development of a European industry under a clear, harmonised regulated framework, the situation also varies for patients. the situation also varies for patients.
#cannabismédical En février déjà je demandais en #plenpe des règles communes et plus de fonds pour la recherche sur le cannabis médical. Je persiste et signe les engagements de @medcannabisEU qui vont dans ce sens. La balle est dans le camp de la @EU_Commission #thc #cbd #Heurope pic.twitter.com/vxwYfrsmCX
— Frédérique Ries (@Frederiqueries) November 19, 2019
For Medicinal Cannabis Europe, Hague defined and implements a EU advocacy strategy. The association advocates for a European approach on medicinal cannabis towards national and European policymakers. Our services to Medicinal Cannabis Europe comprise the full spectrum of public affairs and strategic communication activities: monitoring, intelligence gathering, stakeholder engagement and management, advocacy and communication.
For instance, Hague promotes a policy pledge seeking the support of Members of the European Parliament (MEPs) for the establishment of an EU harmonised regulatory framework on medicinal cannabis and for the allocation of research funds on medicinal cannabis under Horizon Europe, the EU seven-year programme for research and innovation. With the support gained from MEPs on the policy pledge, Medicinal Cannabis Europe has organised its international online conference “Towards a European Approach on Medicinal Cannabis” on 13 October 2020.
As an outcome of the conference, MEPs have committed to work on a Parliament initiative report calling on the Commission to take legislative measures to ensure patients fair access to medicinal cannabis.
Within two years, Hague has managed to profile MCE as a reliable stakeholder representing the medicinal cannabis value chain towards EU institutional stakeholders and is now working with EU policymakers on an policy initiative to ensure patients’ fair access.
Dr. Vincenzo Costigliola, President of MCE, stated:
Today, @brandobenifei 🇮🇹 endorsed our @MedCannabisEU policy pledge 📝💡. Thank you very much for your support! We are looking forward to working with you to ensuring #patients fair access to #medicinalcannabis in 🇪🇺 pic.twitter.com/kg5v6pS7s9
— Medicinal Cannabis Europe (@MedCannabisEU) February 18, 2020
Or follow us
We are happy to help you with our services: